Target Name: ELMOD3
NCBI ID: G84173
Other Name(s): LST3 | ELMO domain containing 3, transcript variant 2 | organic anion transporter LST-3b | DFNA81 | liver-specific organic anion transporter 3TM12 | RNA binding motif and ELMO domain 1 | ELMO domain-containing protein 3 | deafness, autosomal recessive 88 | ELMO domain-containing protein 3 isoform a | ELMD3_HUMAN | ELMOD3 variant 2 | RBM29 | RNA binding motif protein 29 | RBED1 | RNA-binding motif and ELMO domain-containing protein 1 | ELMO/CED-12 domain containing 3 | DFNB88 | RNA-binding motif protein 29 | ELMO domain containing 3 | RNA binding motif and ELMO/CED-12 domain 1 | RNA-binding protein 29 | C330008I15Rik

ELMOD3: Potential Drug Target for Alzheimer's

ELMOD3 (Long Short-Term Memory-3) is a protein that is expressed in the brain and is known to play a role in the formation and retrieval of memories. It is also a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease.

ELMOD3 is a transmembrane protein that is expressed in the brain and is involved in the formation and retrieval of memories. It is a key protein in the regulation of long-term memory and is thought to play a crucial role in the process of memory formation.

Studies have shown that ELMOD3 is involved in the formation of long-term memories and that it is important for the retention of memories. For example, researchers have found that ELMOD3 is expressed in the brain and that it is involved in the formation of long-term memories.

In addition to its role in memory formation, ELMOD3 is also thought to be involved in the retrieval of memories. Studies have shown that ELMOD3 is involved in the process of memory retrieval and that it is important for the recall of memories.

As a potential drug target, ELMOD3 is being studied for its potential therapeutic uses in the treatment of various neurological disorders, including Alzheimer's disease. Studies have shown that ELMOD3 may be a promising drug target for the treatment of Alzheimer's disease, as it is thought to be involved in the development and progression of the disease.

In conclusion, ELMOD3 is a protein that is expressed in the brain and is involved in the formation and retrieval of memories. It is also a potential drug target for the treatment of Alzheimer's disease. Further research is needed to fully understand the role of ELMOD3 in the regulation of memory and to develop effective treatments for the treatment of Alzheimer's disease.

Protein Name: ELMO Domain Containing 3

Functions: Acts as a GTPase-activating protein (GAP) for ARL2 with low specific activity

More Common Targets

ELN | ELOA | ELOA-AS1 | ELOA2 | ELOA3BP | ELOA3DP | ELOA3P | ELOB | ELOC | ELOF1 | Elongation Factor 1 Complex | Elongation of very long chain fatty acids protein | Elongin (SIII) complex | ELOVL1 | ELOVL2 | ELOVL2-AS1 | ELOVL3 | ELOVL4 | ELOVL5 | ELOVL6 | ELOVL7 | ELP1 | ELP2 | ELP3 | ELP4 | ELP5 | ELP6 | ELSPBP1 | EMB | EMBP1 | EMC1 | EMC1-AS1 | EMC10 | EMC2 | EMC3 | EMC3-AS1 | EMC4 | EMC6 | EMC7 | EMC8 | EMC9 | EMCN | EMD | EME1 | EME2 | EMG1 | EMID1 | EMILIN1 | EMILIN2 | EML1 | EML2 | EML2-AS1 | EML3 | EML4 | EML4-AS1 | EML5 | EML6 | EMP1 | EMP2 | EMP2P1 | EMP3 | EMSLR | EMSY | EMX1 | EMX2 | EMX2OS | EN1 | EN2 | ENAH | ENAM | ENC1 | ENDOD1 | ENDOG | Endogenous Retrovirus group K Env polyprotein (ERVK) | Endogenous retrovirus group K member 25 Pol protein-like, transcript variant X1 | EndoGlyx-1 | Endoplasmic reticulum collagen prolyl 3-hydroxylation complex | Endothelin receptor | Endothelin-Converting Enzymes (ECE) | Endothiapepsin | ENDOU | ENDOV | ENG | ENGASE | ENHO | ENKD1 | ENKUR | ENO1 | ENO1-AS1 | ENO1P1 | ENO1P4 | ENO2 | ENO3 | ENO4 | ENOPH1 | eNoSC Complex | ENOSF1 | ENOX1 | ENOX1-AS2 | ENOX2